Active Ingredient History

  • Now
Brilacidin, an investigational new drug (IND), is a polymer-based antibiotic currently in human clinical trials, and represents a new class of antibiotics called host defense protein mimetics, or HDP-mimetics, which are non-peptide synthetic small molecules modeled after host defense peptides (HDPs). HDPs, also called antimicrobial peptides, some of which are defensins, are part of the innate immune response and are common to most higher forms of life. As brilacidin is modeled after a defensin, it is also called a defensin mimetic.   Wikipedia

  • SMILES: NC(=N)NCCCCC(=O)Nc1cc(cc(NC(=O)c2cc(ncn2)C(=O)Nc3cc(cc(NC(=O)CCCCNC(=N)N)c3O[C@@H]4CCNC4)C(F)(F)F)c1O[C@@H]5CCNC5)C(F)(F)F
  • Mol. Mass: 936.92
  • ALogP: 3.68
  • ChEMBL Molecule:
More Chemistry
brilacidin | pmx30063 | pmx-30063


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue